Literature DB >> 25967137

Cluster of Acute Toxicity from Ingestion of Synthetic Cannabinoid-Laced Brownies.

Adebisi I Obafemi1, Kurt Kleinschmidt2, Collin Goto2, Drew Fout3.   

Abstract

INTRODUCTION: Synthetic cannabinoid receptor agonists (SCRAs) are emerging designer drugs of abuse. Most reports on the health effects of these drugs are case reports. Unlike SCRAs, marijuana has classically been used via many routes of exposure including oral, such as in brownies. We report on 11 symptomatic patients who unknowingly ingested brownies laced with analytically confirmed SCRA and presented with mostly neuropsychiatric and cardiovascular symptoms. CASE SERIES: All 11 patients were taken to the ED within 1 h of exposure with the onset of various symptoms. There were five males and six females, age range 20-57 years. Neuropsychiatric and cardiovascular symptoms predominated: memory impairment (91 %, 10/11) and inappropriate giggling (36 %, 4/11). All the patients had light-headedness, perioral and facial numbness and tingling sensation, dry mouth, difficulty focusing/blurring of vision, and sluggishness. No patient had depressed consciousness. Two patients had heart rates >100, and 4 of 11 (36 %) had BP >140/80. One patient had chest pain. All the symptoms were completely resolved 4 h following their onset except two patients who had ongoing weakness and fatigue. All patients had negative urine drugs of abuse immunoassays and ethanol, acetaminophen, and salicylate concentrations, as well as normal electrocardiograms (ECGS) and metabolic panels. The SCRA was confirmed to be AM-2201. All the patients were discharged from the ED in stable condition within 10 h of the exposure.
CONCLUSION: Oral exposure of 11 patients to brownies laced with analytically confirmed SCRA resulted in neuropsychiatric and cardiovascular symptoms. This series reflects that like marijuana, oral exposures to SCRAs can lead to symptoms.

Entities:  

Keywords:  Acute toxicity; Cannabis; Novel psychoactive substance; Synthetic cannabinoid receptor agonists; Tachycardia

Mesh:

Substances:

Year:  2015        PMID: 25967137      PMCID: PMC4675604          DOI: 10.1007/s13181-015-0482-z

Source DB:  PubMed          Journal:  J Med Toxicol        ISSN: 1556-9039


  24 in total

1.  Myocardial infarction associated with use of the synthetic cannabinoid K2.

Authors:  Arshid Mir; Adebisi Obafemi; Amy Young; Colin Kane
Journal:  Pediatrics       Date:  2011-11-07       Impact factor: 7.124

Review 2.  The K2/Spice phenomenon: emergence, identification, legislation and metabolic characterization of synthetic cannabinoids in herbal incense products.

Authors:  Lisa K Brents; Paul L Prather
Journal:  Drug Metab Rev       Date:  2013-09-24       Impact factor: 4.518

3.  An outbreak of exposure to a novel synthetic cannabinoid.

Authors:  Andrew A Monte; Alvin C Bronstein; Dazhe J Cao; Kennon J Heard; Jason A Hoppe; Christopher O Hoyte; Janetta L Iwanicki; Eric J Lavonas
Journal:  N Engl J Med       Date:  2014-01-23       Impact factor: 91.245

4.  First European case of convulsions related to analytically confirmed use of the synthetic cannabinoid receptor agonist AM-2201.

Authors:  David McQuade; Simon Hudson; Paul I Dargan; David M Wood
Journal:  Eur J Clin Pharmacol       Date:  2012-08-31       Impact factor: 2.953

5.  Schedules of controlled substances: temporary placement of four synthetic cannabinoids into Schedule I. Final order.

Authors: 
Journal:  Fed Regist       Date:  2014-02-10

Review 6.  Spicing things up: synthetic cannabinoids.

Authors:  Max Spaderna; Peter H Addy; Deepak Cyril D'Souza
Journal:  Psychopharmacology (Berl)       Date:  2013-07-09       Impact factor: 4.530

7.  Chemical analysis of synthetic cannabinoids as designer drugs in herbal products.

Authors:  Nahoko Uchiyama; Ruri Kikura-Hanajiri; Jun Ogata; Yukihiro Goda
Journal:  Forensic Sci Int       Date:  2010-05-20       Impact factor: 2.395

Review 8.  "Not for human consumption": a review of emerging designer drugs.

Authors:  Megan E Musselman; Jeremy P Hampton
Journal:  Pharmacotherapy       Date:  2014-04-08       Impact factor: 4.705

9.  Synthetic cannabinoid and marijuana exposures reported to poison centers.

Authors:  M B Forrester; K Kleinschmidt; E Schwarz; A Young
Journal:  Hum Exp Toxicol       Date:  2012-08-02       Impact factor: 2.903

Review 10.  Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications.

Authors:  Marisol S Castaneto; David A Gorelick; Nathalie A Desrosiers; Rebecca L Hartman; Sandrine Pirard; Marilyn A Huestis
Journal:  Drug Alcohol Depend       Date:  2014-08-18       Impact factor: 4.492

View more
  6 in total

Review 1.  Role of cannabis in cardiovascular disorders.

Authors:  Hemant Goyal; Hamza H Awad; Jalal K Ghali
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

2.  In Vivo Bio-Activation of JWH-175 to JWH-018: Pharmacodynamic and Pharmacokinetic Studies in Mice.

Authors:  Micaela Tirri; Raffaella Arfè; Sabrine Bilel; Giorgia Corli; Beatrice Marchetti; Anna Fantinati; Fabrizio Vincenzi; Fabio De-Giorgio; Cristian Camuto; Monica Mazzarino; Mario Barbieri; Rosa Maria Gaudio; Katia Varani; Pier Andrea Borea; Francesco Botrè; Matteo Marti
Journal:  Int J Mol Sci       Date:  2022-07-21       Impact factor: 6.208

Review 3.  Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly.

Authors:  Pal Pacher; Sabine Steffens; György Haskó; Thomas H Schindler; George Kunos
Journal:  Nat Rev Cardiol       Date:  2017-09-14       Impact factor: 32.419

4.  Primary Causes of Hospitalizations and Procedures, Predictors of In-hospital Mortality, and Trends in Cardiovascular and Cerebrovascular Events Among Recreational Marijuana Users: A Five-year Nationwide Inpatient Assessment in the United States.

Authors:  Rupak Desai; Sofia Shamim; Krupa Patel; Ashish Sadolikar; Vikram Preet Kaur; Siddhi Bhivandkar; Smit Patel; Sejal Savani; Zeeshan Mansuri; Zabeen Mahuwala
Journal:  Cureus       Date:  2018-08-23

5.  Prevalence and characteristics of cannabis-induced toxicoses in pets: Results from a survey of veterinarians in North America.

Authors:  Richard Quansah Amissah; Nadine A Vogt; Chuyun Chen; Karolina Urban; Jibran Khokhar
Journal:  PLoS One       Date:  2022-04-20       Impact factor: 3.752

Review 6.  Emerging drugs of abuse: current perspectives on synthetic cannabinoids.

Authors:  Danièle Debruyne; Reynald Le Boisselier
Journal:  Subst Abuse Rehabil       Date:  2015-10-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.